ICSI (Intracytoplasmic Sperm Injection) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Meet the families who say we're glorious proof you don't need IVF
Laura underwent two NHS-funded attempts at IVF, using a technique called intracytoplasmic sperm injection (ICSI), where a single sperm was injected into one of Laura's eggs. (Source: the Mail online | Health)
Source: the Mail online | Health - August 27, 2019 Category: Consumer Health News Source Type: news

Podcast: Assisted reproductive technology: an overview of Cochrane Reviews
Cochrane Overviews bring together the findings from multiple reviews and one of the largest, first published in September 2013, was updated and republished in May 2018. Cindy Farquhar, from the Department of Obstetrics and Gynaecology at the University of Auckland in New Zealand describes this enormous volume of evidence for assisted reproduction." Infertility is defined as failure to conceive after one year of trying. Up to one in six couples will experience this at some point in their lives and many will seek fertility treatment in the form of assisted reproduction. When they do so, they will hope that they are getting t...
Source: Cochrane News and Events - August 7, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

European pregnancy rates from IVF and ICSI 'appear to have reached a peak'
(European Society of Human Reproduction and Embryology) The latest annual data collected by ESHRE from European national registries (for 2016) show another rise in the cumulative use of IVF in the treatment of infertility, although success rates after IVF or ICSI appear to have reached a peak, with pregnancy rates per started treatment calculated at 27.1% after IVF and 24.3% after ICSI. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 25, 2019 Category: International Medicine & Public Health Source Type: news

Large cohort study confirms small added obstetric risk from transfer of longer developed embryos
(European Society of Human Reproduction and Embryology) The transfer of embryos cultured for five or six days (instead of two or three) after fertilisation in IVF and ICSI has become routine in many fertility clinics. Many (but not all) studies show that transferring these longer and better developed embryos - known as blastocysts - will increase the chance of pregnancy and live birth. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 24, 2019 Category: International Medicine & Public Health Source Type: news

IVF add-on procedure that costs an extra £1,000 is actually LESS effective for healthy couples
Researchers from the Royal Women's Hospital in Melbourne and Melbourne IVF analysed the results of more than 3,300 IVF cycles and found just 13.6 per cent of ICSI procedures led to births. (Source: the Mail online | Health)
Source: the Mail online | Health - June 11, 2019 Category: Consumer Health News Source Type: news

Older fathers a risk to health of partners and unborn children
Men should be counselled on risks linked to paternal age Related items fromOnMedica Fewer than ever women smoke at point of birth Obese couples take longer to achieve pregnancy Patients face postcode lottery for IVF, new data shows Doctors and midwives welcome clear alcohol advice Doubled use of ICSI did not improve outcomes in US (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 12, 2019 Category: UK Health Source Type: news

No Increased Risk for Cancer for ART - Conceived Children
Slightly but not significantly increased risks seen in children conceived by ICSI or cryopreservation (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 5, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pediatrics, Journal, Source Type: news

Why So Many Women Travel to Denmark for Fertility Treatments
Holly Ryan knows the biological father of her children has two sisters, is a Coldplay fan, and doesn’t like eating chicken in pasta dishes. She knows his mother is a nurse and his father is a policeman, and that his aunt has green eyes and curly hair. She even has a photo of him as a child, and an audio recording of his voice. But Ryan, 41, doesn’t know his name and has never met him. More than six years ago, she decided she wanted to start a family. “Once you commit to trying to get pregnant, it becomes a kind of obsession,” says Ryan, the director of a talent agency for TV directors, producers and...
Source: TIME: Health - January 3, 2019 Category: Consumer Health News Authors: Naina Bajekal/Copenhagen Tags: Uncategorized Denmark Source Type: news

What We're Doing Right And What Can Be Better About IVF
The same vision and imagination that resulted in the invention of IVF, embryo freezing, ICSI, oocyte vitrification, and preimplantation genetics will, with a bit of innovation capital and seed funding, evolve the IVF industry into one of the most important branches of medicine in the 21st-century. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 7, 2018 Category: Pharmaceuticals Authors: David Sable, Contributor Source Type: news

Genetic Testing Doesn't Boost Live-Birth Rates in Older Women Planning ICSI Genetic Testing Doesn't Boost Live-Birth Rates in Older Women Planning ICSI
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 20, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

ICSI treatment linked to increased prostate cancer risk
Men who undergo ICSI (intracytoplasmic sperm injection) are at greater risk of developing prostate cancer, according to a large study presented during the European Society of Human Reproduction and Embryology annual meeting.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 4, 2018 Category: Endocrinology Source Type: news

Sub-fertility in men treated with ICSI associated with an increased risk of prostate cancer
(European Society of Human Reproduction and Embryology) Subfertile men who have received fertility treatment with the microinjection technique of ICSI (intracytoplasmic sperm injection) have been found at a significantly greater risk of prostrate cancer, according to an analysis of three comprehensive nationwide registries in Sweden. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 3, 2018 Category: Cancer & Oncology Source Type: news

Thousands of mobile apps for children might be violating their privacy
(IMDEA Networks Institute) Thousands of the most popular apps and games available, mostly free of charge, in the Google Play Store, make potentially illegal tracking of children's use habits, according to a large-scale international study co-authored by Narseo Vallina-Rodriguez, a researcher at the IMDEA Networks Institute in Madrid and ICSI, the International Computer Science Institute at the University of California, Berkeley (USA). (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 24, 2018 Category: International Medicine & Public Health Source Type: news

FDA clears DxNow ’ s sperm separation device
Medical device developer DxNow said today it won FDA 510(k) clearance for its ZyMōt ICSI and ZyMōt multi sperm separation devices designed for use in assisted reproductive technology procedures. The newly cleared devices from the Gaithersburg, Md.-based company are designed for preparing motile sperm from semen for use in the treatment of infertile couples by intracytoplasmic sperm injection, intrauterine insemination and in vitro fertilization procedures. “We are excited to announce the achievement of this significant milestone in our company’s evolution. This announcement follows CE certification and the in...
Source: Mass Device - March 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance dxnow Source Type: news

DxNow, Inc. Receives FDA 510(k) Clearance for ZyMand#333;t(TM) ICSI and ZyMand#333;t(TM) Multi Sperm Separation Devices
Novel Devices Advance Fertility Treatment for Millions of Couples Striving to Conceive GAITHERSBURG, Md., March 15, 2018 -- (Healthcare Sales & Marketing Network) -- DxNow, Inc., a privately held medical device company, announces receipt of FDA 510(k) ... Devices, FDA DxNow, ZyMōt, assisted reproductive technology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2018 Category: Pharmaceuticals Source Type: news